NOVARTIS
- Country
- ๐จ๐ญSwitzerland
- Ownership
- Public, Private
- Established
- 1996-01-01
- Employees
- 76K
- Market Cap
- $242.6B
A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis B
- Conditions
- First Posted Date
- 2003-03-31
- Last Posted Date
- 2015-03-20
- Lead Sponsor
- Novartis
- Registration Number
- NCT00057265
Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
- Conditions
- Interventions
- First Posted Date
- 2003-03-14
- Last Posted Date
- 2020-02-10
- Lead Sponsor
- Novartis
- Target Recruit Count
- 1168
- Registration Number
- NCT00056459
- Locations
- ๐บ๐ธ
Center for Oncology Research & Treatment, PA, Dallas, Texas, United States
๐บ๐ธUSC/Norris Comprehensive Cancer Care Center, Los Angeles, California, United States
๐บ๐ธPeachtree Hematology and Oncology, Atlanta, Georgia, United States
Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions
- Conditions
- First Posted Date
- 2002-01-10
- Last Posted Date
- 2012-02-01
- Lead Sponsor
- Novartis
- Target Recruit Count
- 500
- Registration Number
- NCT00029224
- Locations
- ๐บ๐ธ
Osceola Cancer Center, Kissimmee, Florida, United States
๐บ๐ธStockton Hematology Oncology Medical Group, Stockton, California, United States
๐บ๐ธHematology-Oncology Associates PC, Albuquerque, New Mexico, United States
Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Novartis
- Target Recruit Count
- 30
- Registration Number
- NCT00002394
- Locations
- ๐บ๐ธ
Univ of Texas Med Branch, Galveston, Texas, United States
๐บ๐ธHampton Roads Med Specialists, Hampton, Virginia, United States
๐บ๐ธTherafirst Med Ctr, Fort Lauderdale, Florida, United States
Investigation Into Delay to Diagnosis of Alzheimer's Disease With Exelon (InDDEx)
- Conditions
- First Posted Date
- 1999-11-01
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Novartis
- Registration Number
- NCT00000174
- Locations
- ๐บ๐ธ
St. Louis University, St. Louis, Missouri, United States
๐บ๐ธClinical Studies, Ltd., Philadelphia, Philadelphia, Pennsylvania, United States
๐บ๐ธSt. Paul Medical Center, Dallas, Texas, United States